TrialAnnals of surgical oncology2022

Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.

Olga Kantor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.